SCM Lifescience Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 55

Employees

  • Stock Symbol
  • 298060

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.80
  • (As of Monday Closing)

SCM Lifescience General Information

Description

SCM Lifescience Co Ltd is engaged in the research and development of medicines, hair care medicines, stem cell products in South Korea.

Contact Information

Website
www.scmlifescience.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 7-7, Gaetbeol-ro 145beon-gil
  • 7-28, Songdo-dong, Yeonsu-gu
  • Incheon, 21999
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
KRX
Vertical(s)
Life Sciences
Corporate Office
  • 7-7, Gaetbeol-ro 145beon-gil
  • 7-28, Songdo-dong, Yeonsu-gu
  • Incheon, 21999
  • South Korea
+82

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SCM Lifescience Stock Performance

As of 24-Mar-2025, SCM Lifescience’s stock price is $0.80. Its current market cap is $16.3M with 20.5M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.80 $0.91 $0.69 - $2.41 $16.3M 20.5M 464K -$0.56

SCM Lifescience Financials Summary

As of 30-Sep-2024, SCM Lifescience has a trailing 12-month revenue of $661K.

In Thousands,
USD 		TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 32,873 51,162 135,615 185,167
Revenue 661 532 306 383
EBITDA (11,091) (17,512) (16,947) (18,672)
Net Income (11,629) (18,327) (17,746) (19,660)
Total Assets 14,393 19,713 26,146 45,415
Total Debt 3,096 2,963 4,568 5,185
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SCM Lifescience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SCM Lifescience‘s full profile, request access.

Request a free trial

SCM Lifescience Patents

  • 65

    Total Documents Applications and Grants

  • Total Patents Families

  • 33

    Granted

  • 25

    Pending

  • Expiring in next 12 mo

SCM Lifescience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240277772-A1 Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells Pending 01-Jun-2021
CA-3225620-A1 Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells Pending 01-Jun-2021
EP-4342479-A1 Composition containing function-reinforced stem cell for prevention or treatment of atopic dermatitis Pending 18-May-2021
US-20240216438-A1 Composition containing function-reinforced stem cell for prevention or treatment of atopic dermatitis Pending 18-May-2021
AU-2021410513-A1 Stem cell priming composition and primed stem cell Pending 23-Dec-2020 C12N5/0662
To view SCM Lifescience’s complete patent history, request access »

SCM Lifescience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SCM Lifescience Investments & Acquisitions (2)

SCM Lifescience’s most recent deal was a Early Stage VC with Vita Therapeutics for . The deal was made on 23-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vita Therapeutics 23-Jun-2021 Early Stage VC Biotechnology
Argos Therapeutics 13-Feb-2019 Merger/Acquisition Drug Discovery
To view SCM Lifescience’s complete investments and acquisitions history, request access »

SCM Lifescience ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view SCM Lifescience’s complete esg history, request access »

SCM Lifescience FAQs

  • When was SCM Lifescience founded?

    SCM Lifescience was founded in 2014.

  • Where is SCM Lifescience headquartered?

    SCM Lifescience is headquartered in Incheon, South Korea.

  • What is the size of SCM Lifescience?

    SCM Lifescience has 55 total employees.

  • What industry is SCM Lifescience in?

    SCM Lifescience’s primary industry is Drug Discovery.

  • Is SCM Lifescience a private or public company?

    SCM Lifescience is a Public company.

  • What is SCM Lifescience’s stock symbol?

    The ticker symbol for SCM Lifescience is 298060.

  • What is the current stock price of SCM Lifescience?

    As of 24-Mar-2025 the stock price of SCM Lifescience is $0.80.

  • What is the current market cap of SCM Lifescience?

    The current market capitalization of SCM Lifescience is $16.3M.

  • What is SCM Lifescience’s current revenue?

    The trailing twelve month revenue for SCM Lifescience is $661K.

  • What is SCM Lifescience’s annual earnings per share (EPS)?

    SCM Lifescience’s EPS for 12 months was -$0.56.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »